CIK 0001710072 · Large accelerated filer
Edgewise Therapeutics, Inc.
Sign in to watch- Ticker
- EWTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 821725586
- Phone
- 720-262-7002
- Business address
- 1715 38TH ST, BOULDER, CO, 80301
- 10-Q Report Quarterly Report
- 144 Insider Sale of Securities
- 4 Open-market sale CMO sold 55,230 shares at an average $37.88 ($2,092,063)
- SCHEDULE 13D/A Stake Beneficial Ownership Report
- ARS Other Annual Report to Security Holders
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- 4 Grant or award Director acquired 339 shares (grant or award)
- 4 Planned sale CMO sold 28,662 shares at $32.31 ($926,095)
- 4 Planned sale CMO sold 21,338 shares at $32.12 ($685,308)
- 4 Planned sale CMO sold 16,358 shares at $30.98 ($506,735)
- 144 Insider Sale of Securities
- 10-K Report Annual Report
- 8-K Event Results of operations
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 4 Planned sale Director sold 115,471 shares at $29.44 ($3,399,466)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Grant or award Director acquired 473 shares (grant or award)
Page 3 of 22 · 423 filings